TABLE 1.
The preparation mechanisms and relevant drug release behaviors of NG-DDS.
| Network structure | Cross-linking mechanism | The nanogel size | The loaded molecule | Stimuli-responsive drug release | References |
|---|---|---|---|---|---|
| Chemical cross-linking | Traditional free radical polymerization | 90–230 nm | Doxorubicin | pH/thermo | Wang et al. (2015) |
| Controllable/living free radical polymerization | 82–153 nm | Coumarin 102 | UV light | Xin et al. (2020) | |
| Disulfide, imine cross-linking | 250 nm | Doxorubicin | pH/redox | Pei et al. (2018) | |
| Click reaction | 236 nm | Labeled insulin | Glucose/H2O2 | Li et al. (2019a) | |
| Physical cross-linking | Hydrophilic and hydrophobic interactions | 55.7–259.2 nm | Nile Red | pH | Wang et al. (2018) |
| Supramolecular host-guest assembly | 108.1–121.4 nm | Doxorubicin and indocyanine green | NIR light | Zan et al. (2015) | |
| Hydrophobic/electrostatic interactions | 140–230 nm | Curcumin | pH/oxidation | Dong et al. (2020) | |
| Hydrogen bonds | 230 nm | DAPI, fluorescein, Nile red | Thermo | Zavgorodnya et al. (2017) | |
| Both | Disulfide cross-linking/hydrophobic interactions | 66.95 ± 1.93 nm | Purpurin 18 and 10-hydroxycamplothecin | Redox | Ma et al. (2021) |
| Free radical polymerization/hydrogen bonds | 18 nm | Curcumin | Thermo/NIR light | Wang et al. (2014) | |
| Free radical polymerization/disulfide cross-linking/ electrostatic interactions | 70 nm | Doxorubicin | pH/thermo/photo | Chen et al. (2017) |